Neonatal Meningitis-Causing Escherichia coli Induces Microglia Activation which Acts as a Double-Edged Sword in Bacterial Meningitis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24129915 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yingying Su und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, Nankai University, Tianjin 300457, China. Hauptthemen laut MEDLINE: Meningitis, Escherichia coli, Meningitis, Bacterial, Escherichia coli Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of China (NSFC) Program.
Abstract (Originalsprache)
Bacterial meningitis is a devastating disease occurring worldwide, with up to half of survivors left with permanent neurological sequelae. Neonatal meningitis-causing Escherichia coli (NMEC) is the most common Gram-negative bacillary organism that causes meningitis, particularly during the neonatal period. Here, RNA-seq transcriptional profiles of microglia in response to NMEC infection show that microglia are activated to produce inflammatory factors. In addition, we found that the secretion of inflammatory factors is a double-edged sword that promotes polymorphonuclear neutrophil (PMN) recruitment to the brain to clear the pathogens but, at the same time, induces neuronal damage, which may be related to the neurological sequelae. New neuroprotective therapeutic strategies must be developed for the treatment of acute bacterial meningitis. We found that transforming growth factor-β (TGF-β) may be a strong candidate in the treatment of acute bacterial meningitis, as it shows a therapeutic effect on bacterial-meningitis-induced brain damage. Prevention of disease and early initiation of the appropriate treatment in patients with suspected or proven bacterial meningitis are the key factors in reducing morbidity and mortality. Novel antibiotic and adjuvant treatment strategies must be developed, and the main goal for new therapies will be dampening the inflammatory response. Based on this view, our findings may help develop novel strategies for bacterial meningitis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, Nankai University, Tianjin 300457, China.
- Tianjin Key Laboratory of Microbial Functional Genomics, TEDA Institute of Biological Sciences and Biotechnology, Nankai University, Tianjin 300457, China.
ORCID-Profile: Yingying Su, Jingliang Qin
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation of China (NSFC) Program
Zitieren
APA
Su, Y., Ma, G., Zheng, Y., Qin, J., Li, X., Ge, Q., Sun, H., & Liu, B. (2023). Neonatal Meningitis-Causing Escherichia coli Induces Microglia Activation which Acts as a Double-Edged Sword in Bacterial Meningitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24129915
Vancouver
Su Y, Ma G, Zheng Y, Qin J, Li X, Ge Q, et al. Neonatal Meningitis-Causing Escherichia coli Induces Microglia Activation which Acts as a Double-Edged Sword in Bacterial Meningitis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24129915
BibTeX
@article{Su2023,
author = {Su, Yingying and Ma, Guozhen and Zheng, Yangyang and Qin, Jingliang and Li, Xiaoya and Ge, Qianwen and Sun, Hao and Liu, Bin},
title = {Neonatal Meningitis-Causing Escherichia coli Induces Microglia Activation which Acts as a Double-Edged Sword in Bacterial Meningitis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24129915}
}
EUVIMED